Parallel Advisors, LLC - ASTERIAS BIOTHERAPEUTICS INC ownership

ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 75 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 6.89 and the average weighting 0.0%.

Quarter-by-quarter ownership
Parallel Advisors, LLC ownership history of ASTERIAS BIOTHERAPEUTICS INC
ValueSharesWeighting
Q4 2018$0
-100.0%
200
-94.6%
0.00%
-100.0%
Q3 2018$5,0000.0%3,7380.0%0.00%0.0%
Q2 2018$5,0000.0%3,7380.0%0.00%0.0%
Q1 2018$5,000
-37.5%
3,738
+5.7%
0.00%0.0%
Q4 2017$8,0000.0%3,5380.0%0.00%0.0%
Q3 2017$8,000
-38.5%
3,5380.0%0.00%
-50.0%
Q2 2017$13,000
-40.9%
3,538
-50.0%
0.00%0.0%
Q1 2017$22,000
+37.5%
7,076
+100.0%
0.00%
-50.0%
Q4 2016$16,0003,5380.00%
Other shareholders
ASTERIAS BIOTHERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 5,292,156$7,144,0000.82%
Northeast Financial Consultants Inc 732,265$988,0000.30%
Family Management Corp 10,424$14,0000.01%
LMR Partners LLP 81,550$110,0000.01%
ELEMENT CAPITAL MANAGEMENT LLC 148,528$201,0000.01%
Poehling Capital Management, INC. 3,302$4,0000.00%
Paloma Partners Management Co 143,800$194,0000.00%
Founders Capital Management 3,000$4,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 186,254$251,0000.00%
FNY Investment Advisers, LLC 4,230$5,0000.00%
View complete list of ASTERIAS BIOTHERAPEUTICS INC shareholders